Seroprevalence and Molecular Epidemiology of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2 in Blood Donors from Dakar, Senegal
Domain:
healthcareCreator:
SalSarJulDou
Publisher:
Ame
Host:
ABSTRACT
In 2002, human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 seroprevalence was 0.16% (8/4,900) in blood donors from Dakar, Senegal. Most of the positive donors originated from the country’s southern region. Seven donors were infected by HTLV-1 (of cosmopolitan subtype), and one was infected by HTLV-2. These data highlight the problem of transfusion safety in this area where HTLV-1-associated lymphoproliferative and neurological diseases are endemic.
Similar
Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in PygmiesSeroprevalence and risk factors for human T cell lymphotropic viruses types 1 and 2 among blood donors in Jos, NigeriaAfrican Origin of Human T-Lymphotropic Virus Type 2 (HTLV-2) Supported by a Potential New HTLV-2d Subtype in Congolese Bambuti Efe PygmiesHuman T-Cell Lymphotropic Virus (HTLV-1) Infection in the Democratic Republic of the Congo: A Review of a Forgotten EpidemicIsolation and molecular characterization of a human T-cell lymphotropic virus type II (HTLV-II), subtype B, from a healthy Pygmy living in a remote area of Cameroon: an ancient origin for HTLV-II in Africa.Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes